A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions
Authors:
- Gabriel Marcelín-JiménezGMGabriel Marcelín-Jiménez
- Alionka P. Angeles-MorenoAAAlionka P. Angeles-Moreno
- Leticia Contreras-ZavalaLCLeticia Contreras-Zavala
- Miriam Morales-MartínezMMMiriam Morales-Martínez
- Liliana Rivera-EspinosaLRLiliana Rivera-Espinosa
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 31 (9) , 2002-2011
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MSJournal of Chromatography B, 2007
- Distinct absorption characteristics of oral formulations of valproic acid/divalproex available in the United StatesEpilepsy Research, 2007
- Development and validation of a sensitive assay of valproic acid in human plasma by high-performance liquid chromatography without prior derivatizationJournal of Chromatography B, 2006
- Liquid chromatography/electrospray ionization mass spectrometry method for the quantification of valproic acid in human plasmaRapid Communications in Mass Spectrometry, 2005
- Study of bioequivalence of magnesium and sodium valproatesJournal of Pharmaceutical and Biomedical Analysis, 1991
- Clinical Pharmacokinetics of Valproic Acid - 1988Clinical Pharmacokinetics, 1988
- Accumulation and Washout Kinetics of Valproic Acid and Its Active MetabolitesThe Journal of Clinical Pharmacology, 1986
- Concentration-Effect Relationships of Valproic AcidClinical Pharmacokinetics, 1985
- Bioavailability of Calcium Valproate in Normal Men Compared with the Free Acid and Sodium SaltTherapeutic Drug Monitoring, 1983